Intra-Cellular Therapies
ITCI
#1744
Rank
HK$75.23 B
Marketcap
HK$709.64
Share price
0.86%
Change (1 day)
69.98%
Change (1 year)

EPS for Intra-Cellular Therapies (ITCI)

EPS in 2023 (TTM): -HK$12.61

According to Intra-Cellular Therapies's latest financial reports the company's current EPS (TTM) is -HK$12.52. In 2022 the company made an earnings per share (EPS) of -HK$21.14 an increase over its 2021 EPS that were of -HK$27.21.

EPS history for Intra-Cellular Therapies from 2014 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-HK$12.61-40.35%
2022-HK$21.14-22.29%
2021-HK$27.218.02%
2020-HK$25.1920.9%
2019-HK$20.83-5.63%
2018-HK$22.0833.96%
2017-HK$16.48-21.19%
2016-HK$20.91-7.56%
2015-HK$22.62174.53%
2014-HK$8.24

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-HK$1.94-84.47%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$77.73 521.12%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$16.64 32.92%๐Ÿ‡บ๐Ÿ‡ธ USA